Full Press Release Details
Lisa Carey has served as our Vice President, Clinical Operations since May 2023. Ms. Carey has over 30 years of clinical operations experience. From June 2015 to December 2023, she served as our Sr. Director, Clinical Operations, overseeing the company’s clinical programs, including efzofitimod. Prior to joining aTyr, from 2006 to 2015, Ms. Carey worked at Vertex Pharmaceuticals as a Clinical Operations Consultant in the Global Trial Activation Group, where she facilitated global Phase 3 trials for Kalydeco® for the treatment of cystic fibrosis, Incivek® for hepatitis C and lumacaftor for the treatment of cystic fibrosis. From 1997 to 2003, Ms. Carey was as an Associate Director, Global Study Management, Experimental Medicine in the areas of oncology and infectious disease at the Genetics Institute/Wyeth Pharmaceuticals, and from 1995 to 1997, she served as a Project Manager in asthma at Muro Pharmaceutical, Inc. Prior to entering into clinical operations research, Ms. Carey was a critical care nurse. Ms. Carey has a B.S. in Nursing from Saint Joseph’s College.